Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
4(21%)
Results Posted
17%(1 trials)
Terminated
2(11%)

Phase Distribution

Ph not_applicable
7
37%
Ph phase_3
3
16%
Ph phase_4
1
5%
Ph phase_2
5
26%

Phase Distribution

0

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution16 total trials
Phase 2Efficacy & side effects
5(31.3%)
Phase 3Large-scale testing
3(18.8%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
7(43.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(5)
Completed(6)
Terminated(3)
Other(5)

Detailed Status

Completed6
unknown5
Recruiting3
Terminated2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (31.3%)
Phase 33 (18.8%)
Phase 41 (6.3%)
N/A7 (43.8%)

Trials by Status

completed632%
active_not_recruiting15%
not_yet_recruiting15%
recruiting316%
unknown526%
terminated211%
withdrawn15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04409600Phase 2

Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)

Completed
NCT03938363Not Applicable

Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia

Completed
NCT07082972Phase 4

EMG-Based Evaluation of Occlusal Splint and Masseter Botox Effects on Head and Neck Muscles

Recruiting
NCT05874154Not Applicable

Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach

Recruiting
NCT07013240Phase 3

Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact

Not Yet Recruiting
NCT06765694

Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study (EPITOX)

Active Not Recruiting
NCT04722809Phase 3

Efficacy of Botulinum Toxin A in the Treatment of Bruxism-related Symptomatology

Terminated
NCT04220931Not Applicable

Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula

Recruiting
NCT04550793

Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients

Unknown
NCT01935544Not Applicable

Effectiveness of Two Techniques in Injection Site Spotting for Botulinum Toxin Injections: Echography or Electro Stimulation.

Completed
NCT03904004

Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study

Unknown
NCT02917967Not Applicable

A Pilot Study of the Effect of Botulinum Toxin Type a (Dysport®, Abobotulinum Toxin A) Injection on Changes in Musculotendinous Length and Dynamics of Hamstring Muscles During Gait in Children With Spastic Cerebral Palsy Walking With Excessive Knee Flexion

Completed
NCT02837185Not Applicable

Effects of Botulinum Toxin on Muscle and Brain Activity

Terminated
NCT02663206Not Applicable

Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders

Withdrawn
NCT02617069Phase 2

Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Unknown
NCT03119948Phase 2

Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis

Unknown
NCT02008461Phase 2

Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

Unknown
NCT01842529Phase 2

Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery

Completed
NCT00825097Phase 3

Efficacy Study of Selective Tibial Neurotomy in the Treatment of the Spastic Equinovarus Foot Among Adult Hemiplegic Patients

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19